Cataracts, the leading cause of blindness, affect some 120 million people worldwide, but only an estimated 15% of people with cataracts are being treated with cataract removal surgery, which provides
The worldwide glaucoma market, worth over $4 billion annually, has been dominated for decades by drug therapy, which accounts for approximately 95% of the total market. The emergence of a high-growth
In Vitro Diagnostics KellBenx Inc. Seed funding brings in $2.4mm for KellBenx KellBenx Inc. (noninvasive prenatal diagnostics for genetic disorders) has raised $2.4mm through its seed round. Of th
by Mary Stuart Despite decades of effort, the treatment of glaucoma, the second leading cause of blindness in the world, has the hallmark of a clinical field that's still somewhat early in its develop